SA
IPOAX logo
Macquarie Systematic Emerging Markets Equity Fund A(IPOAX)
Last print unknown agoAbout this dataData status
$23.04▲0.07 (0.30%)Stale · unknown old

S&P 500, Nasdaq, Russell 2000 below the 200-day average · VIX 25.4 · elevated volatility

Overview →

Nomura Systematic Emerging Markets Eq A (IPOAX)

R&D to Revenue

No reported values are currently available. Missing values are not treated as zero.

What is r&d to revenue?

R&D spending as percentage of revenue.

IPOAX r&d to revenue history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

Frequently asked questions: IPOAX r&d to revenue

What does r&d to revenue measure for Nomura Systematic Emerging Markets Eq A (IPOAX)?

R&D spending as percentage of revenue. Stock Alarm Pro tracks Nomura Systematic Emerging Markets Eq A (IPOAX)'s r&d to revenue across annual fiscal periods reporting periods.

How can I compare IPOAX's r&d to revenue to peers or set an alert?

You can open IPOAX's r&d to revenue in Stock Alarm Pro Chart Studio to overlay price and valuation multiples, or set real-time alerts on IPOAX delivered by push, email, or phone call.

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.